Reframing medical collaboration with structured expertise
Our capability model combines clinical understanding, service delivery and digital organization to support hospitals, academic teams and regional partners.
- Keep clinical value at the center of product and service design.
- Build long-term trust through quality, compliance and academic alignment.
- Prepare content and architecture for future mini program and App expansion.

Play Company Introduction
Corporate News & Academic Updates
Four Technology Platforms
Cytopathology, immunopathology, histopathology and digital pathology — covering the full cancer screening workflow.
Cytopathology Platform
TCT testing, DNA ploidy quantitative analysis and multi-specimen cytology AI-assisted diagnosis covering cervical cancer and other tumor early screening.
- TCT testing
- DNA ploidy analysis
- AI-assisted cytology
Immunopathology Platform
HPV E6/E7 detection, P16/Ki-67 dual-stain, immunohistochemistry stainer and more for precise immuno-pathology labeling and analysis.
- HPV E6/E7 detection
- P16/Ki-67 dual-stain
- IHC stainer
Histopathology Platform
Cryosection, dehydration, embedding and other full-process histopathology equipment and companion reagents.
- Cryostat
- Tissue processor
- Embedding center
Digital Pathology Platform
Fully automated digital slide scanners, AI-assisted diagnostic systems and remote consultation platforms empowering pathology department digitization and intelligence.
- Digital slide scanner
- AI-assisted diagnosis
- Remote consultation
Upgrade innovation, collaboration and service delivery together
If you are looking for a product partner, a consultation workflow or a business collaboration path, we are ready to discuss.

![Hubei Liantou [e-Enterprise Connect] | Heer Medical Brings AI Technology to Grassroots, Addressing Key Health Challenges](/images/news/2026-05-14-eAI/1.webp)


![[Cytopathology Annual Meeting Review] Heer Medical Shines at the 24th National Cytopathology Annual Meeting](/images/academic/2026-06-17-细胞病理年会精彩回顾呵尔医疗亮相第二十四届全国细胞病理学年会/1.webp)

